These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31378074)

  • 1. Benefit of Digital Tools Used for Integrated Personalized Diabetes Management: Results From the PDM-ProValue Study Program.
    Heinemann L; Schramm W; Koenig H; Moritz A; Vesper I; Weissmann J; Kulzer B
    J Diabetes Sci Technol; 2020 Mar; 14(2):240-249. PubMed ID: 31378074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program.
    Kulzer B; Daenschel W; Daenschel I; Schramm W; Messinger D; Weissmann J; Vesper I; Parkin CG; Heinemann L
    Diabetes Res Clin Pract; 2018 Oct; 144():200-212. PubMed ID: 30205184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Personalized Diabetes Management (PDM): Design of the ProValue Studies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the Effectiveness and Benefit of PDM in Patients With Insulin-Treated Type 2 Diabetes.
    Kulzer B; Daenschel W; Daenschel I; Siegel EG; Schramm W; Parkin CG; Messinger D; Weissmann J; Djuric Z; Mueller A; Vesper I; Heinemann L
    J Diabetes Sci Technol; 2016 May; 10(3):772-81. PubMed ID: 26645793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe.
    Jones A; Bardram JE; Bækgaard P; Cramer-Petersen CL; Skinner T; Vrangbæk K; Starr L; Nørgaard K; Lind N; Bechmann Christensen M; Glümer C; Wang-Sattler R; Laxy M; Brander E; Heinemann L; Heise T; Schliess F; Ladewig K; Kownatka D
    Prim Care Diabetes; 2021 Apr; 15(2):360-364. PubMed ID: 33184011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-centred care in type 2 diabetes mellitus - Key aspects of PDM-ProValue are reflected in the 2018 ADA/EASD consensus report.
    Fritzen K; Stautner C; Schnell O
    Diabetes Res Clin Pract; 2019 Dec; 158():107897. PubMed ID: 31672502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing use of patient-focused pharmacotherapy in glycemic management through the Diabetes Collaborative Registry (DCR).
    Arnold SV; McGuire DK; Inzucchi SE; Tang F; Mehta SN; Lam CSP; Goyal A; Sperling LS; Wong ND; Hammar N; Fenici P; Kosiborod M
    J Diabetes Complications; 2018 Nov; 32(11):1035-1039. PubMed ID: 30177468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study.
    Campbell MD; Babic D; Bolcina U; Smirčić-Duvnjak L; Tankova T; Mitrakou A; Kempler P; Janez A
    Acta Diabetol; 2019 Sep; 56(9):1045-1049. PubMed ID: 30993528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating Integrated Personalised Diabetes Management (iPDM) in Treatment Strategy: A Pragmatic Approach.
    Kalra S; Bantwal G; Sahay RK; Bhattacharya S; Baruah MP; Sheikh S; Lathia T
    Indian J Endocrinol Metab; 2022; 26(2):106-110. PubMed ID: 35873934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a health education technology program on long-term glycemic control and self-management ability of adults with type 2 diabetes: A randomized controlled trial.
    Pai LW; Chiu SC; Liu HL; Chen LL; Peng T
    Diabetes Res Clin Pract; 2021 May; 175():108785. PubMed ID: 33781794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of glycemic control after decline of insulin therapy by patients with type 2 diabetes.
    Florez L; Shubina M; Turchin A
    J Diabetes Complications; 2019 Nov; 33(11):107418. PubMed ID: 31477552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family physician clinical inertia in glycemic control among patients with type 2 diabetes.
    Bralić Lang V; Bergman Marković B; Kranjčević K
    Med Sci Monit; 2015 Feb; 21():403-11. PubMed ID: 25652941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative evaluation of a physician-delivered pedometer-based step count prescription strategy with insight from participants and treating physicians.
    Cooke AB; Pace R; Chan D; Rosenberg E; Dasgupta K; Daskalopoulou SS
    Diabetes Res Clin Pract; 2018 May; 139():314-322. PubMed ID: 29530385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is meant by 'integrated personalized diabetes management': A view into the future and what success should look like.
    Guldemond N
    Diabetes Obes Metab; 2024 Mar; 26 Suppl 1():14-29. PubMed ID: 38328815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modular ICT-based patient empowerment framework for self-management of diabetes: Design perspectives and validation results.
    Lamprinos I; Demski H; Mantwill S; Kabak Y; Hildebrand C; Ploessnig M
    Int J Med Inform; 2016 Jul; 91():31-43. PubMed ID: 27185507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IMPROVE study--a multinational, observational study in type 2 diabetes: data from the Polish cohort.
    Gumprecht J; Zurawska G; Wolnik B; Dzida G
    Endokrynol Pol; 2008; 59(6):460-6. PubMed ID: 19347809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors for Supporting Primary Care Physician Engagement With Patient Apps for Type 2 Diabetes Self-Management That Link to Primary Care: Interview Study.
    Ayre J; Bonner C; Bramwell S; McClelland S; Jayaballa R; Maberly G; McCaffery K
    JMIR Mhealth Uhealth; 2019 Jan; 7(1):e11885. PubMed ID: 30664468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators.
    JAMA; 1995 Nov 22-29; 274(20):1591-8. PubMed ID: 7474243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers for integrating personalized medicine into clinical practice: a qualitative analysis.
    Najafzadeh M; Davis JC; Joshi P; Marra C
    Am J Med Genet A; 2013 Apr; 161A(4):758-63. PubMed ID: 23444119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redesigning Primary Care to Improve Diabetes Outcomes (the UNITED Study).
    Peterson KA; Carlin C; Solberg LI; Jacobsen R; Kriel T; Eder M
    Diabetes Care; 2020 Mar; 43(3):549-555. PubMed ID: 31882407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitating participatory decision-making: what happens in real-world community practice?
    Gotler RS; Flocke SA; Goodwin MA; Zyzanski SJ; Murray TH; Stange KC
    Med Care; 2000 Dec; 38(12):1200-9. PubMed ID: 11186299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.